MX2011008131A - Lineas celulares que expresan cftr y los métodos para utilizarlas. - Google Patents
Lineas celulares que expresan cftr y los métodos para utilizarlas.Info
- Publication number
- MX2011008131A MX2011008131A MX2011008131A MX2011008131A MX2011008131A MX 2011008131 A MX2011008131 A MX 2011008131A MX 2011008131 A MX2011008131 A MX 2011008131A MX 2011008131 A MX2011008131 A MX 2011008131A MX 2011008131 A MX2011008131 A MX 2011008131A
- Authority
- MX
- Mexico
- Prior art keywords
- cftr
- cell
- cells
- intron
- suppression
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 93
- 210000004027 cell Anatomy 0.000 claims description 825
- 108010079245 Cystic Fibrosis Transmembrane Conductance Regulator Proteins 0.000 claims description 397
- 102000012605 Cystic Fibrosis Transmembrane Conductance Regulator Human genes 0.000 claims description 396
- 108020004999 messenger RNA Proteins 0.000 claims description 134
- 108090000623 proteins and genes Proteins 0.000 claims description 118
- 238000003556 assay Methods 0.000 claims description 96
- 150000001875 compounds Chemical class 0.000 claims description 94
- 102000004169 proteins and genes Human genes 0.000 claims description 89
- 238000012360 testing method Methods 0.000 claims description 87
- 230000008859 change Effects 0.000 claims description 76
- 238000004113 cell culture Methods 0.000 claims description 73
- 230000014509 gene expression Effects 0.000 claims description 67
- 150000007523 nucleic acids Chemical class 0.000 claims description 62
- 230000001766 physiological effect Effects 0.000 claims description 59
- 230000012010 growth Effects 0.000 claims description 54
- 239000012528 membrane Substances 0.000 claims description 54
- 102000039446 nucleic acids Human genes 0.000 claims description 49
- 108020004707 nucleic acids Proteins 0.000 claims description 49
- 230000032258 transport Effects 0.000 claims description 37
- 230000001413 cellular effect Effects 0.000 claims description 35
- 239000002773 nucleotide Substances 0.000 claims description 34
- 125000003729 nucleotide group Chemical group 0.000 claims description 33
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 32
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 30
- 229920001184 polypeptide Polymers 0.000 claims description 27
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 20
- 230000004913 activation Effects 0.000 claims description 18
- 108091005957 yellow fluorescent proteins Proteins 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 17
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims description 13
- 238000002955 isolation Methods 0.000 claims description 12
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 12
- 210000000170 cell membrane Anatomy 0.000 claims description 11
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims description 9
- 101000907783 Homo sapiens Cystic fibrosis transmembrane conductance regulator Proteins 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 9
- 102000056427 human CFTR Human genes 0.000 claims description 9
- 238000012545 processing Methods 0.000 claims description 9
- 230000000116 mitigating effect Effects 0.000 claims description 7
- 150000003384 small molecules Chemical class 0.000 claims description 7
- 238000000159 protein binding assay Methods 0.000 claims description 5
- 210000004962 mammalian cell Anatomy 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 3
- 238000003306 harvesting Methods 0.000 claims description 3
- 102000035195 Peptidases Human genes 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 108010067902 Peptide Library Proteins 0.000 claims description 2
- 238000010353 genetic engineering Methods 0.000 claims 1
- 235000019833 protease Nutrition 0.000 claims 1
- 238000000423 cell based assay Methods 0.000 abstract description 7
- 230000001629 suppression Effects 0.000 description 261
- 230000007547 defect Effects 0.000 description 151
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 128
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 113
- 238000003780 insertion Methods 0.000 description 92
- 230000037431 insertion Effects 0.000 description 92
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 90
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 90
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 83
- 235000018102 proteins Nutrition 0.000 description 83
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 82
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 80
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 74
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 68
- 239000000523 sample Substances 0.000 description 68
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 63
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 59
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 59
- 210000004379 membrane Anatomy 0.000 description 53
- 230000000694 effects Effects 0.000 description 52
- 230000035772 mutation Effects 0.000 description 50
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 47
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 47
- 208000015532 congenital bilateral absence of vas deferens Diseases 0.000 description 45
- 230000011664 signaling Effects 0.000 description 43
- 238000012217 deletion Methods 0.000 description 41
- 230000037430 deletion Effects 0.000 description 41
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 38
- SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 37
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 37
- OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 37
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 34
- 108700024394 Exon Proteins 0.000 description 31
- 108020004705 Codon Proteins 0.000 description 30
- 230000006870 function Effects 0.000 description 30
- 235000001014 amino acid Nutrition 0.000 description 29
- 230000002068 genetic effect Effects 0.000 description 28
- 230000004044 response Effects 0.000 description 28
- 239000003814 drug Substances 0.000 description 25
- 150000001413 amino acids Chemical class 0.000 description 24
- 229940079593 drug Drugs 0.000 description 24
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 23
- 239000000556 agonist Substances 0.000 description 23
- 229940024606 amino acid Drugs 0.000 description 23
- 238000006467 substitution reaction Methods 0.000 description 23
- 239000000975 dye Substances 0.000 description 22
- 239000003153 chemical reaction reagent Substances 0.000 description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 20
- 210000001519 tissue Anatomy 0.000 description 19
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 17
- 241000699670 Mus sp. Species 0.000 description 17
- 239000003242 anti bacterial agent Substances 0.000 description 17
- 239000012091 fetal bovine serum Substances 0.000 description 17
- 239000008103 glucose Substances 0.000 description 17
- 239000013598 vector Substances 0.000 description 17
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 16
- 239000007995 HEPES buffer Substances 0.000 description 16
- 229940088710 antibiotic agent Drugs 0.000 description 16
- 239000002609 medium Substances 0.000 description 16
- 239000003795 chemical substances by application Substances 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 14
- 241000282414 Homo sapiens Species 0.000 description 13
- 229910002092 carbon dioxide Inorganic materials 0.000 description 13
- 239000003550 marker Substances 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 12
- 238000005259 measurement Methods 0.000 description 12
- 230000004048 modification Effects 0.000 description 12
- 238000012986 modification Methods 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 12
- 230000014616 translation Effects 0.000 description 12
- 101150029409 CFTR gene Proteins 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- 238000012512 characterization method Methods 0.000 description 11
- 230000002028 premature Effects 0.000 description 11
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 239000001110 calcium chloride Substances 0.000 description 10
- 235000011148 calcium chloride Nutrition 0.000 description 10
- 229910001628 calcium chloride Inorganic materials 0.000 description 10
- 229950010131 puromycin Drugs 0.000 description 10
- 230000028327 secretion Effects 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- -1 correctors Substances 0.000 description 9
- 150000002632 lipids Chemical class 0.000 description 9
- 102000036364 Cullin Ring E3 Ligases Human genes 0.000 description 8
- 239000005557 antagonist Substances 0.000 description 8
- 238000010367 cloning Methods 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 239000013641 positive control Substances 0.000 description 8
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 108091006146 Channels Proteins 0.000 description 7
- 201000003883 Cystic fibrosis Diseases 0.000 description 7
- 239000012190 activator Substances 0.000 description 7
- 230000000295 complement effect Effects 0.000 description 7
- 238000002591 computed tomography Methods 0.000 description 7
- 239000003623 enhancer Substances 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 238000002825 functional assay Methods 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- 230000001976 improved effect Effects 0.000 description 7
- 239000003112 inhibitor Substances 0.000 description 7
- 230000010354 integration Effects 0.000 description 7
- 210000003463 organelle Anatomy 0.000 description 7
- 230000000144 pharmacologic effect Effects 0.000 description 7
- 230000035479 physiological effects, processes and functions Effects 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 6
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 206010059866 Drug resistance Diseases 0.000 description 6
- KAKJTZWHIUWTTD-VQVTYTSYSA-N Met-Thr Chemical compound CSCC[C@H]([NH3+])C(=O)N[C@@H]([C@@H](C)O)C([O-])=O KAKJTZWHIUWTTD-VQVTYTSYSA-N 0.000 description 6
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 6
- 108700019146 Transgenes Proteins 0.000 description 6
- 230000004888 barrier function Effects 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 210000003169 central nervous system Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000012160 loading buffer Substances 0.000 description 6
- 229910001629 magnesium chloride Inorganic materials 0.000 description 6
- 238000012423 maintenance Methods 0.000 description 6
- 230000007170 pathology Effects 0.000 description 6
- 239000004224 potassium gluconate Substances 0.000 description 6
- 235000013926 potassium gluconate Nutrition 0.000 description 6
- 229960003189 potassium gluconate Drugs 0.000 description 6
- 238000003908 quality control method Methods 0.000 description 6
- 102000005962 receptors Human genes 0.000 description 6
- 108020003175 receptors Proteins 0.000 description 6
- 239000000176 sodium gluconate Substances 0.000 description 6
- 235000012207 sodium gluconate Nutrition 0.000 description 6
- 229940005574 sodium gluconate Drugs 0.000 description 6
- 238000010561 standard procedure Methods 0.000 description 6
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 231100000673 dose–response relationship Toxicity 0.000 description 5
- 210000002919 epithelial cell Anatomy 0.000 description 5
- 230000004907 flux Effects 0.000 description 5
- 230000030279 gene silencing Effects 0.000 description 5
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 239000005090 green fluorescent protein Substances 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000013537 high throughput screening Methods 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 238000010606 normalization Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000035882 stress Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 238000001890 transfection Methods 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- KSXTUUUQYQYKCR-LQDDAWAPSA-M 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KSXTUUUQYQYKCR-LQDDAWAPSA-M 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102100023509 Chloride channel protein 2 Human genes 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 4
- HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 4
- 101000906633 Homo sapiens Chloride channel protein 2 Proteins 0.000 description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
- IMTUWVJPCQPJEE-IUCAKERBSA-N Met-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN IMTUWVJPCQPJEE-IUCAKERBSA-N 0.000 description 4
- 102000005431 Molecular Chaperones Human genes 0.000 description 4
- 108010006519 Molecular Chaperones Proteins 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 229930193140 Neomycin Natural products 0.000 description 4
- 241000288906 Primates Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 206010040007 Sense of oppression Diseases 0.000 description 4
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000006978 adaptation Effects 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 4
- 238000004422 calculation algorithm Methods 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 230000022131 cell cycle Effects 0.000 description 4
- 230000032823 cell division Effects 0.000 description 4
- 230000036755 cellular response Effects 0.000 description 4
- 210000003756 cervix mucus Anatomy 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 229960004927 neomycin Drugs 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 210000000496 pancreas Anatomy 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 230000019100 sperm motility Effects 0.000 description 4
- 230000010473 stable expression Effects 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 239000004474 valine Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108700028369 Alleles Proteins 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 206010010356 Congenital anomaly Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 241000699802 Cricetulus griseus Species 0.000 description 3
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 230000004543 DNA replication Effects 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 108091006027 G proteins Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- KNPVDQMEHSCAGX-UWVGGRQHSA-N Phe-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 KNPVDQMEHSCAGX-UWVGGRQHSA-N 0.000 description 3
- 108010029485 Protein Isoforms Proteins 0.000 description 3
- 102000001708 Protein Isoforms Human genes 0.000 description 3
- 108020005067 RNA Splice Sites Proteins 0.000 description 3
- 108091036066 Three prime untranslated region Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000001464 adherent effect Effects 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 206010003883 azoospermia Diseases 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- ZOOGRGPOEVQQDX-KHLHZJAASA-N cyclic guanosine monophosphate Chemical compound C([C@H]1O2)O[P@](O)(=O)O[C@@H]1[C@H](O)[C@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-KHLHZJAASA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 238000007876 drug discovery Methods 0.000 description 3
- 230000007831 electrophysiology Effects 0.000 description 3
- 238000002001 electrophysiology Methods 0.000 description 3
- 210000001671 embryonic stem cell Anatomy 0.000 description 3
- 210000003158 enteroendocrine cell Anatomy 0.000 description 3
- 210000001508 eye Anatomy 0.000 description 3
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
- 238000002599 functional magnetic resonance imaging Methods 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 208000002551 irritable bowel syndrome Diseases 0.000 description 3
- 229960000310 isoleucine Drugs 0.000 description 3
- 230000004807 localization Effects 0.000 description 3
- 238000002826 magnetic-activated cell sorting Methods 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 210000003470 mitochondria Anatomy 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 231100000219 mutagenic Toxicity 0.000 description 3
- 230000003505 mutagenic effect Effects 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 231100000065 noncytotoxic Toxicity 0.000 description 3
- 230000002020 noncytotoxic effect Effects 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 208000008634 oligospermia Diseases 0.000 description 3
- 230000036616 oligospermia Effects 0.000 description 3
- 231100000528 oligospermia Toxicity 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- 238000007747 plating Methods 0.000 description 3
- 230000004481 post-translational protein modification Effects 0.000 description 3
- 230000009145 protein modification Effects 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 238000005215 recombination Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000001360 synchronised effect Effects 0.000 description 3
- 239000012096 transfection reagent Substances 0.000 description 3
- 230000009261 transgenic effect Effects 0.000 description 3
- 230000010474 transient expression Effects 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 2
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 2
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 2
- WBSMIPAMAXNXFS-UHFFFAOYSA-N 5-Nitro-2-(3-phenylpropylamino)benzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1NCCCC1=CC=CC=C1 WBSMIPAMAXNXFS-UHFFFAOYSA-N 0.000 description 2
- 102000014156 AMP-Activated Protein Kinases Human genes 0.000 description 2
- 108010011376 AMP-Activated Protein Kinases Proteins 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 2
- 241000726103 Atta Species 0.000 description 2
- NTTIDCCSYIDANP-UHFFFAOYSA-N BCCP Chemical compound BCCP NTTIDCCSYIDANP-UHFFFAOYSA-N 0.000 description 2
- 101710201279 Biotin carboxyl carrier protein Proteins 0.000 description 2
- 101710180532 Biotin carboxyl carrier protein of acetyl-CoA carboxylase Proteins 0.000 description 2
- 210000003771 C cell Anatomy 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010008631 Cholera Diseases 0.000 description 2
- 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 2
- 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- 230000033616 DNA repair Effects 0.000 description 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 2
- 206010013774 Dry eye Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- 102000030782 GTP binding Human genes 0.000 description 2
- 108091000058 GTP-Binding Proteins 0.000 description 2
- 206010017918 Gastroenteritis viral Diseases 0.000 description 2
- 208000010412 Glaucoma Diseases 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 102100022662 Guanylyl cyclase C Human genes 0.000 description 2
- OOFLZRMKTMLSMH-UHFFFAOYSA-N H4atta Chemical compound OC(=O)CN(CC(O)=O)CC1=CC=CC(C=2N=C(C=C(C=2)C=2C3=CC=CC=C3C=C3C=CC=CC3=2)C=2N=C(CN(CC(O)=O)CC(O)=O)C=CC=2)=N1 OOFLZRMKTMLSMH-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101001125417 Homo sapiens Na(+)/H(+) exchange regulatory cofactor NHE-RF3 Proteins 0.000 description 2
- 108090000862 Ion Channels Proteins 0.000 description 2
- 102000004310 Ion Channels Human genes 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 2
- 238000004497 NIR spectroscopy Methods 0.000 description 2
- 102100029467 Na(+)/H(+) exchange regulatory cofactor NHE-RF3 Human genes 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 241000009328 Perro Species 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 101800004937 Protein C Proteins 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- 206010037423 Pulmonary oedema Diseases 0.000 description 2
- 108091030071 RNAI Proteins 0.000 description 2
- 239000012891 Ringer solution Substances 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- 101800001700 Saposin-D Proteins 0.000 description 2
- 102400000827 Saposin-D Human genes 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 102000002933 Thioredoxin Human genes 0.000 description 2
- 108010022394 Threonine synthase Proteins 0.000 description 2
- 102000006601 Thymidine Kinase Human genes 0.000 description 2
- 108020004440 Thymidine kinase Proteins 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 108010003205 Vasoactive Intestinal Peptide Proteins 0.000 description 2
- 102400000015 Vasoactive intestinal peptide Human genes 0.000 description 2
- 241000234314 Zingiber Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 2
- 229940117893 apigenin Drugs 0.000 description 2
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 2
- 235000008714 apigenin Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 229940009098 aspartate Drugs 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzene carboxamide Natural products NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 2
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000005388 borosilicate glass Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 102220403531 c.3739G>A Human genes 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000002659 cell therapy Methods 0.000 description 2
- 230000033077 cellular process Effects 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 238000000975 co-precipitation Methods 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 239000000412 dendrimer Substances 0.000 description 2
- 229920000736 dendritic polymer Polymers 0.000 description 2
- 230000030609 dephosphorylation Effects 0.000 description 2
- 238000009543 diffuse optical tomography Methods 0.000 description 2
- 102000004419 dihydrofolate reductase Human genes 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000007877 drug screening Methods 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 230000009144 enzymatic modification Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000037433 frameshift Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- CBCIHIVRDWLAME-UHFFFAOYSA-N hexanitrodiphenylamine Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O CBCIHIVRDWLAME-UHFFFAOYSA-N 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000000099 in vitro assay Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 238000001638 lipofection Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000003712 lysosome Anatomy 0.000 description 2
- 230000001868 lysosomic effect Effects 0.000 description 2
- 230000021121 meiosis Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 210000000282 nail Anatomy 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000001937 non-anti-biotic effect Effects 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 210000000633 nuclear envelope Anatomy 0.000 description 2
- 239000002853 nucleic acid probe Substances 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 238000004091 panning Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 235000013930 proline Nutrition 0.000 description 2
- 229960000856 protein c Drugs 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 208000005333 pulmonary edema Diseases 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 102200132116 rs113857788 Human genes 0.000 description 2
- 102200128204 rs121909005 Human genes 0.000 description 2
- 102200128595 rs35516286 Human genes 0.000 description 2
- 102220019738 rs397507909 Human genes 0.000 description 2
- 102200128271 rs397508316 Human genes 0.000 description 2
- 102200128274 rs397508338 Human genes 0.000 description 2
- 102220020833 rs397508796 Human genes 0.000 description 2
- 102220294268 rs773509355 Human genes 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 210000004739 secretory vesicle Anatomy 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000002741 site-directed mutagenesis Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 229960002232 sodium phenylbutyrate Drugs 0.000 description 2
- VPZRWNZGLKXFOE-UHFFFAOYSA-M sodium phenylbutyrate Chemical compound [Na+].[O-]C(=O)CCCC1=CC=CC=C1 VPZRWNZGLKXFOE-UHFFFAOYSA-M 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 230000008010 sperm capacitation Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 230000004960 subcellular localization Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 108060008226 thioredoxin Proteins 0.000 description 2
- 229940094937 thioredoxin Drugs 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 210000002105 tongue Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- UYPYRKYUKCHHIB-UHFFFAOYSA-N trimethylamine N-oxide Chemical compound C[N+](C)(C)[O-] UYPYRKYUKCHHIB-UHFFFAOYSA-N 0.000 description 2
- 210000003934 vacuole Anatomy 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 210000001177 vas deferen Anatomy 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- BEJKOYIMCGMNRB-GRHHLOCNSA-N (2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 BEJKOYIMCGMNRB-GRHHLOCNSA-N 0.000 description 1
- FMKJUUQOYOHLTF-OWOJBTEDSA-N (e)-4-azaniumylbut-2-enoate Chemical compound NC\C=C\C(O)=O FMKJUUQOYOHLTF-OWOJBTEDSA-N 0.000 description 1
- VADKRMSMGWJZCF-UHFFFAOYSA-N 2-bromophenol Chemical compound OC1=CC=CC=C1Br VADKRMSMGWJZCF-UHFFFAOYSA-N 0.000 description 1
- GWRSATNRNFYMDI-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound FC=1C=C(NC=2N=C3N(C4CCCC4)CC(F)(F)C(=O)N(C)C3=CN=2)C(OC)=CC=1C(=O)NC1CCN(C)CC1 GWRSATNRNFYMDI-UHFFFAOYSA-N 0.000 description 1
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 1
- FJNFVCAHHFNREI-UHFFFAOYSA-N 4-cyclohexyloxy-2-[1-[4-(4-methoxyphenyl)sulfonylpiperazin-1-yl]ethyl]quinazoline Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N1CCN(C(C)C=2N=C3C=CC=CC3=C(OC3CCCCC3)N=2)CC1 FJNFVCAHHFNREI-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- XGWFJBFNAQHLEF-UHFFFAOYSA-N 9-anthroic acid Chemical compound C1=CC=C2C(C(=O)O)=C(C=CC=C3)C3=CC2=C1 XGWFJBFNAQHLEF-UHFFFAOYSA-N 0.000 description 1
- 102000041092 ABC transporter family Human genes 0.000 description 1
- 108091060858 ABC transporter family Proteins 0.000 description 1
- 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 1
- 102100037232 Amiloride-sensitive sodium channel subunit beta Human genes 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 101100509648 Catharanthus roseus AKN gene Proteins 0.000 description 1
- 102000011045 Chloride Channels Human genes 0.000 description 1
- 108010062745 Chloride Channels Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 101710164760 Chlorotoxin Proteins 0.000 description 1
- HVSJHHXUORMCGK-UONOGXRCSA-N Chromanol 293B Chemical compound C1=C(C#N)C=C2[C@H](N(C)S(=O)(=O)CC)[C@@H](O)C(C)(C)OC2=C1 HVSJHHXUORMCGK-UONOGXRCSA-N 0.000 description 1
- 101100007328 Cocos nucifera COS-1 gene Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 102100036219 Cyclic nucleotide-gated olfactory channel Human genes 0.000 description 1
- 102220530829 Cystic fibrosis transmembrane conductance regulator_D651N_mutation Human genes 0.000 description 1
- 102220537371 Cystic fibrosis transmembrane conductance regulator_P1072L_mutation Human genes 0.000 description 1
- 102220530827 Cystic fibrosis transmembrane conductance regulator_T665S_mutation Human genes 0.000 description 1
- 102100037186 Cytochrome b-245 chaperone 1 Human genes 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 206010012742 Diarrhoea infectious Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 102000003837 Epithelial Sodium Channels Human genes 0.000 description 1
- 108090000140 Epithelial Sodium Channels Proteins 0.000 description 1
- 241001505295 Eros Species 0.000 description 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 102220576640 Fibrocystin_L1096R_mutation Human genes 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000034286 G proteins Human genes 0.000 description 1
- 206010017943 Gastrointestinal conditions Diseases 0.000 description 1
- 102100039696 Glutamate-cysteine ligase catalytic subunit Human genes 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 239000008777 Glycerylphosphorylcholine Substances 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102100040870 Glycine amidinotransferase, mitochondrial Human genes 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 108010078321 Guanylate Cyclase Proteins 0.000 description 1
- 102000014469 Guanylate cyclase Human genes 0.000 description 1
- 101710198293 Guanylyl cyclase C Proteins 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 241001272567 Hominoidea Species 0.000 description 1
- 101000678026 Homo sapiens Alpha-1-antichymotrypsin Proteins 0.000 description 1
- 101000740426 Homo sapiens Amiloride-sensitive sodium channel subunit beta Proteins 0.000 description 1
- 101000875054 Homo sapiens Cyclic nucleotide-gated olfactory channel Proteins 0.000 description 1
- 101001034527 Homo sapiens Glutamate-cysteine ligase catalytic subunit Proteins 0.000 description 1
- 101000893303 Homo sapiens Glycine amidinotransferase, mitochondrial Proteins 0.000 description 1
- 101000899808 Homo sapiens Guanylyl cyclase C Proteins 0.000 description 1
- 101001056128 Homo sapiens Mannose-binding protein C Proteins 0.000 description 1
- 101000928278 Homo sapiens Natriuretic peptides B Proteins 0.000 description 1
- 101000620620 Homo sapiens Placental protein 13-like Proteins 0.000 description 1
- 101000684919 Homo sapiens Sodium- and chloride-dependent creatine transporter 1 Proteins 0.000 description 1
- 101001046427 Homo sapiens cGMP-dependent protein kinase 2 Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 239000012097 Lipofectamine 2000 Substances 0.000 description 1
- 102220522517 Low-density lipoprotein receptor-related protein 5_W79R_mutation Human genes 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
- 102100026553 Mannose-binding protein C Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 208000019209 Monosomy 22 Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 102100036836 Natriuretic peptides B Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- 102000006478 Protein Phosphatase 2 Human genes 0.000 description 1
- 108010058956 Protein Phosphatase 2 Proteins 0.000 description 1
- 108010010469 Qa-SNARE Proteins Proteins 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 102000042463 Rho family Human genes 0.000 description 1
- 108091078243 Rho family Proteins 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 102000000583 SNARE Proteins Human genes 0.000 description 1
- 108010041948 SNARE Proteins Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 241000872198 Serjania polyphylla Species 0.000 description 1
- 206010049416 Short-bowel syndrome Diseases 0.000 description 1
- 108010003723 Single-Domain Antibodies Proteins 0.000 description 1
- 102100023153 Sodium- and chloride-dependent creatine transporter 1 Human genes 0.000 description 1
- 102000052126 Sodium-Hydrogen Exchangers Human genes 0.000 description 1
- 108091006672 Sodium–hydrogen antiporter Proteins 0.000 description 1
- 102220599629 Spindlin-1_Q1071H_mutation Human genes 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 102000050389 Syntaxin Human genes 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 108010084455 Zeocin Proteins 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 208000037883 airway inflammation Diseases 0.000 description 1
- 150000001294 alanine derivatives Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 229940125516 allosteric modulator Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000006909 anti-apoptosis Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 229930189065 blasticidin Natural products 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 102220384477 c.1420G>A Human genes 0.000 description 1
- 102220403544 c.1550A>G Human genes 0.000 description 1
- 102220450760 c.1586A>G Human genes 0.000 description 1
- 102200132121 c.1616T>C Human genes 0.000 description 1
- 102220403547 c.1654C>A Human genes 0.000 description 1
- 102220402626 c.2672A>G Human genes 0.000 description 1
- 102220377303 c.2733T>G Human genes 0.000 description 1
- 102220377302 c.3803A>G Human genes 0.000 description 1
- 102220384476 c.3806T>A Human genes 0.000 description 1
- 102220397079 c.3846G>C Human genes 0.000 description 1
- 102220377295 c.3868C>A Human genes 0.000 description 1
- 102220350570 c.410T>C Human genes 0.000 description 1
- 102220397148 c.4264C>T Human genes 0.000 description 1
- 102220384478 c.44T>C Human genes 0.000 description 1
- 102220395081 c.473G>A Human genes 0.000 description 1
- 102220457761 c.581G>T Human genes 0.000 description 1
- 102100022421 cGMP-dependent protein kinase 2 Human genes 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 210000004671 cell-free system Anatomy 0.000 description 1
- 230000030570 cellular localization Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- FLASNYPZGWUPSU-SICDJOISSA-N chitosan Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H](O[C@@H](O[C@@H]2[C@H](O[C@@H](O)[C@H](N)[C@H]2O)CO)[C@H](N)[C@H]1O)CO)NC(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1N FLASNYPZGWUPSU-SICDJOISSA-N 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- QPAKKWCQMHUHNI-GQIQPHNSSA-N chlorotoxin Chemical compound C([C@H]1C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]4CSSC[C@@H](C(N[C@@H](CCSC)C(=O)N5CCC[C@H]5C(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC2=O)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC4=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N3)=O)NC(=O)[C@@H](N)CCSC)C1=CC=C(O)C=C1 QPAKKWCQMHUHNI-GQIQPHNSSA-N 0.000 description 1
- 229960005534 chlorotoxin Drugs 0.000 description 1
- SUHOQUVVVLNYQR-MRVPVSSYSA-N choline alfoscerate Chemical compound C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000002806 clathrin-coated vesicle Anatomy 0.000 description 1
- 230000004186 co-expression Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 210000001100 crypt cell Anatomy 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 101150064521 cybC1 gene Proteins 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 230000000459 effect on growth Effects 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 230000002121 endocytic effect Effects 0.000 description 1
- 210000001900 endoderm Anatomy 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 210000001163 endosome Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 210000002322 enterochromaffin cell Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- USYYTAZBXJZVHZ-UHFFFAOYSA-N ethanesulfonic acid;methane Chemical compound C.CCS(O)(=O)=O USYYTAZBXJZVHZ-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000003636 fecal output Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 229960004580 glibenclamide Drugs 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 102000005396 glutamine synthetase Human genes 0.000 description 1
- 108020002326 glutamine synthetase Proteins 0.000 description 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 1
- 229960004956 glycerylphosphorylcholine Drugs 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 210000002288 golgi apparatus Anatomy 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000012203 high throughput assay Methods 0.000 description 1
- 238000012188 high-throughput screening assay Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 229940006461 iodide ion Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000012007 large scale cell culture Methods 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- WDRYRZXSPDWGEB-UHFFFAOYSA-N lonidamine Chemical compound C12=CC=CC=C2C(C(=O)O)=NN1CC1=CC=C(Cl)C=C1Cl WDRYRZXSPDWGEB-UHFFFAOYSA-N 0.000 description 1
- 229960003538 lonidamine Drugs 0.000 description 1
- 210000005265 lung cell Anatomy 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000007898 magnetic cell sorting Methods 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 238000002582 magnetoencephalography Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 150000003956 methylamines Chemical class 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000008555 neuronal activation Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- IHRSXGONVFFQQF-SDXDJHTJSA-N nitrazine Chemical compound OS(=O)(=O)C1=CC2=CC(S(O)(=O)=O)=CC=C2C(=O)\C1=N/NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O IHRSXGONVFFQQF-SDXDJHTJSA-N 0.000 description 1
- 125000000449 nitro group Chemical class [O-][N+](*)=O 0.000 description 1
- 235000021231 nutrient uptake Nutrition 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 239000004031 partial agonist Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 208000028591 pheochromocytoma Diseases 0.000 description 1
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000009822 protein phosphorylation Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000004800 psychological effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 102000016949 rab GTP-Binding Proteins Human genes 0.000 description 1
- 108010014420 rab GTP-Binding Proteins Proteins 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 210000003935 rough endoplasmic reticulum Anatomy 0.000 description 1
- 102200128582 rs113993958 Human genes 0.000 description 1
- 102220020622 rs113993958 Human genes 0.000 description 1
- 102220339061 rs113993958 Human genes 0.000 description 1
- 102200128619 rs115545701 Human genes 0.000 description 1
- 102220243437 rs115762793 Human genes 0.000 description 1
- 102220339025 rs1180803268 Human genes 0.000 description 1
- 102200132106 rs11971167 Human genes 0.000 description 1
- 102220289339 rs1204521684 Human genes 0.000 description 1
- 102200128615 rs121908750 Human genes 0.000 description 1
- 102200128616 rs121908751 Human genes 0.000 description 1
- 102200128186 rs121908752 Human genes 0.000 description 1
- 102200128167 rs121908753 Human genes 0.000 description 1
- 102200128203 rs121908755 Human genes 0.000 description 1
- 102200128206 rs121908755 Human genes 0.000 description 1
- 102200128232 rs121908758 Human genes 0.000 description 1
- 102200128270 rs121908759 Human genes 0.000 description 1
- 102200128187 rs121908802 Human genes 0.000 description 1
- 102200128188 rs121908803 Human genes 0.000 description 1
- 102200128225 rs121909006 Human genes 0.000 description 1
- 102220020418 rs121909006 Human genes 0.000 description 1
- 102200128252 rs121909008 Human genes 0.000 description 1
- 102200128180 rs121909009 Human genes 0.000 description 1
- 102200128201 rs121909011 Human genes 0.000 description 1
- 102200128220 rs121909013 Human genes 0.000 description 1
- 102200132109 rs121909015 Human genes 0.000 description 1
- 102200128198 rs121909016 Human genes 0.000 description 1
- 102200128176 rs121909017 Human genes 0.000 description 1
- 102200132020 rs121909019 Human genes 0.000 description 1
- 102200132029 rs121909019 Human genes 0.000 description 1
- 102200132037 rs121909020 Human genes 0.000 description 1
- 102220020605 rs121909020 Human genes 0.000 description 1
- 102220002744 rs121909021 Human genes 0.000 description 1
- 102220020709 rs121909026 Human genes 0.000 description 1
- 102200132112 rs121909028 Human genes 0.000 description 1
- 102200128585 rs121909031 Human genes 0.000 description 1
- 102200128251 rs121909034 Human genes 0.000 description 1
- 102200128259 rs121909035 Human genes 0.000 description 1
- 102200132021 rs121909036 Human genes 0.000 description 1
- 102200132022 rs121909036 Human genes 0.000 description 1
- 102200132031 rs121909037 Human genes 0.000 description 1
- 102200132014 rs121909040 Human genes 0.000 description 1
- 102200132013 rs121909041 Human genes 0.000 description 1
- 102200132107 rs121909042 Human genes 0.000 description 1
- 102200128217 rs121909044 Human genes 0.000 description 1
- 102220002772 rs121909046 Human genes 0.000 description 1
- 102200128230 rs121909047 Human genes 0.000 description 1
- 102200058925 rs121909538 Human genes 0.000 description 1
- 102220198275 rs121918454 Human genes 0.000 description 1
- 102220020563 rs137975784 Human genes 0.000 description 1
- 102220020811 rs138338446 Human genes 0.000 description 1
- 102220020380 rs138427145 Human genes 0.000 description 1
- 102200132039 rs139304906 Human genes 0.000 description 1
- 102200128264 rs139468767 Human genes 0.000 description 1
- 102220262154 rs139729994 Human genes 0.000 description 1
- 102220020488 rs140455771 Human genes 0.000 description 1
- 102200128583 rs140502196 Human genes 0.000 description 1
- 102220020598 rs140883683 Human genes 0.000 description 1
- 102200128256 rs141033578 Human genes 0.000 description 1
- 102220020673 rs141723617 Human genes 0.000 description 1
- 102200132023 rs142394380 Human genes 0.000 description 1
- 102220020487 rs142540482 Human genes 0.000 description 1
- 102220020551 rs142773283 Human genes 0.000 description 1
- 102220036669 rs143009528 Human genes 0.000 description 1
- 102220020451 rs143036685 Human genes 0.000 description 1
- 102220339095 rs1434504483 Human genes 0.000 description 1
- 102200128606 rs143456784 Human genes 0.000 description 1
- 102200128199 rs143486492 Human genes 0.000 description 1
- 102220289350 rs143860237 Human genes 0.000 description 1
- 102200132024 rs144055758 Human genes 0.000 description 1
- 102220270321 rs1441163505 Human genes 0.000 description 1
- 102220008594 rs144476686 Human genes 0.000 description 1
- 102200128280 rs145449046 Human genes 0.000 description 1
- 102220020718 rs145545286 Human genes 0.000 description 1
- 102220020743 rs145900055 Human genes 0.000 description 1
- 102220018788 rs146463120 Human genes 0.000 description 1
- 102220289416 rs146463120 Human genes 0.000 description 1
- 102220020634 rs146521846 Human genes 0.000 description 1
- 102220020635 rs146521846 Human genes 0.000 description 1
- 102200128163 rs147422190 Human genes 0.000 description 1
- 102220350642 rs148013312 Human genes 0.000 description 1
- 102220020832 rs148519623 Human genes 0.000 description 1
- 102220020758 rs148783445 Human genes 0.000 description 1
- 102220020585 rs149279509 Human genes 0.000 description 1
- 102200128605 rs149353983 Human genes 0.000 description 1
- 102200132025 rs150212784 Human genes 0.000 description 1
- 102220020654 rs150326506 Human genes 0.000 description 1
- 102220020734 rs150683293 Human genes 0.000 description 1
- 102200128200 rs150691494 Human genes 0.000 description 1
- 102220020371 rs151020603 Human genes 0.000 description 1
- 102200128257 rs151048781 Human genes 0.000 description 1
- 102220008593 rs151073129 Human genes 0.000 description 1
- 102220313065 rs1553261932 Human genes 0.000 description 1
- 102220339054 rs1554376431 Human genes 0.000 description 1
- 102220289383 rs1554381352 Human genes 0.000 description 1
- 102220261652 rs1554389245 Human genes 0.000 description 1
- 102220339202 rs1554394076 Human genes 0.000 description 1
- 102220339159 rs1554395363 Human genes 0.000 description 1
- 102220243440 rs1554397584 Human genes 0.000 description 1
- 102220323998 rs1555224039 Human genes 0.000 description 1
- 102200128608 rs1800073 Human genes 0.000 description 1
- 102200128604 rs1800074 Human genes 0.000 description 1
- 102200128620 rs1800076 Human genes 0.000 description 1
- 102220020489 rs1800076 Human genes 0.000 description 1
- 102200128593 rs1800079 Human genes 0.000 description 1
- 102220020813 rs1800081 Human genes 0.000 description 1
- 102200128195 rs1800085 Human genes 0.000 description 1
- 102200128166 rs1800086 Human genes 0.000 description 1
- 102220289282 rs1800086 Human genes 0.000 description 1
- 102200128164 rs1800087 Human genes 0.000 description 1
- 102200128181 rs1800089 Human genes 0.000 description 1
- 102200128173 rs1800091 Human genes 0.000 description 1
- 102220020389 rs1800091 Human genes 0.000 description 1
- 102220020395 rs1800095 Human genes 0.000 description 1
- 102200128227 rs1800097 Human genes 0.000 description 1
- 102200128228 rs1800097 Human genes 0.000 description 1
- 102200128243 rs1800098 Human genes 0.000 description 1
- 102200128273 rs1800100 Human genes 0.000 description 1
- 102200128278 rs1800103 Human genes 0.000 description 1
- 102200128255 rs1800110 Human genes 0.000 description 1
- 102200128253 rs1800111 Human genes 0.000 description 1
- 102200132026 rs1800112 Human genes 0.000 description 1
- 102200132038 rs1800114 Human genes 0.000 description 1
- 102220020607 rs1800114 Human genes 0.000 description 1
- 102200130905 rs1801177 Human genes 0.000 description 1
- 102220020580 rs184724618 Human genes 0.000 description 1
- 102220020608 rs186045772 Human genes 0.000 description 1
- 102200128192 rs191456345 Human genes 0.000 description 1
- 102220008541 rs193922497 Human genes 0.000 description 1
- 102220008545 rs193922500 Human genes 0.000 description 1
- 102200128213 rs193922504 Human genes 0.000 description 1
- 102200128247 rs193922506 Human genes 0.000 description 1
- 102200128250 rs193922511 Human genes 0.000 description 1
- 102200128261 rs193922516 Human genes 0.000 description 1
- 102220008569 rs193922516 Human genes 0.000 description 1
- 102220008576 rs193922518 Human genes 0.000 description 1
- 102200132105 rs193922525 Human genes 0.000 description 1
- 102220020808 rs193922529 Human genes 0.000 description 1
- 102220020481 rs199791061 Human genes 0.000 description 1
- 102200132035 rs200321110 Human genes 0.000 description 1
- 102220020480 rs200531709 Human genes 0.000 description 1
- 102200132027 rs200553511 Human genes 0.000 description 1
- 102220319541 rs200955612 Human genes 0.000 description 1
- 102200128238 rs201124247 Human genes 0.000 description 1
- 102220020508 rs201386642 Human genes 0.000 description 1
- 102220339066 rs201444561 Human genes 0.000 description 1
- 102220020725 rs201686600 Human genes 0.000 description 1
- 102220020540 rs201759207 Human genes 0.000 description 1
- 102220020848 rs201885470 Human genes 0.000 description 1
- 102220020490 rs201888075 Human genes 0.000 description 1
- 102200128587 rs201958172 Human genes 0.000 description 1
- 102200128240 rs201978662 Human genes 0.000 description 1
- 102200132034 rs202179988 Human genes 0.000 description 1
- 102200132017 rs267606723 Human genes 0.000 description 1
- 102220002773 rs267606723 Human genes 0.000 description 1
- 102200132016 rs34911792 Human genes 0.000 description 1
- 102220020764 rs35516286 Human genes 0.000 description 1
- 102200132009 rs36210737 Human genes 0.000 description 1
- 102200132012 rs36210737 Human genes 0.000 description 1
- 102220020794 rs367850319 Human genes 0.000 description 1
- 102200128612 rs368505753 Human genes 0.000 description 1
- 102220020531 rs369521395 Human genes 0.000 description 1
- 102220123350 rs371107552 Human genes 0.000 description 1
- 102220020537 rs373885282 Human genes 0.000 description 1
- 102220020538 rs373885282 Human genes 0.000 description 1
- 102220289446 rs374403559 Human genes 0.000 description 1
- 102220339122 rs374453187 Human genes 0.000 description 1
- 102220338814 rs374702882 Human genes 0.000 description 1
- 102220289450 rs376968326 Human genes 0.000 description 1
- 102220217059 rs377295859 Human genes 0.000 description 1
- 102220020502 rs377447726 Human genes 0.000 description 1
- 102220008566 rs386134230 Human genes 0.000 description 1
- 102220002745 rs387906368 Human genes 0.000 description 1
- 102220020349 rs397508137 Human genes 0.000 description 1
- 102220020350 rs397508137 Human genes 0.000 description 1
- 102200128202 rs397508139 Human genes 0.000 description 1
- 102220020353 rs397508142 Human genes 0.000 description 1
- 102220020354 rs397508144 Human genes 0.000 description 1
- 102200128170 rs397508146 Human genes 0.000 description 1
- 102220020264 rs397508147 Human genes 0.000 description 1
- 102220020359 rs397508154 Human genes 0.000 description 1
- 102220020360 rs397508155 Human genes 0.000 description 1
- 102220450949 rs397508165 Human genes 0.000 description 1
- 102220018593 rs397508166 Human genes 0.000 description 1
- 102220018701 rs397508170 Human genes 0.000 description 1
- 102220019659 rs397508170 Human genes 0.000 description 1
- 102220019084 rs397508177 Human genes 0.000 description 1
- 102220019112 rs397508180 Human genes 0.000 description 1
- 102220020364 rs397508185 Human genes 0.000 description 1
- 102220020365 rs397508187 Human genes 0.000 description 1
- 102220020368 rs397508191 Human genes 0.000 description 1
- 102220338798 rs397508191 Human genes 0.000 description 1
- 102200128183 rs397508195 Human genes 0.000 description 1
- 102220020372 rs397508202 Human genes 0.000 description 1
- 102220020379 rs397508210 Human genes 0.000 description 1
- 102220020382 rs397508214 Human genes 0.000 description 1
- 102220020383 rs397508214 Human genes 0.000 description 1
- 102220020385 rs397508217 Human genes 0.000 description 1
- 102220020386 rs397508219 Human genes 0.000 description 1
- 102200128614 rs397508220 Human genes 0.000 description 1
- 102220020387 rs397508221 Human genes 0.000 description 1
- 102220020388 rs397508222 Human genes 0.000 description 1
- 102200128177 rs397508223 Human genes 0.000 description 1
- 102220020390 rs397508224 Human genes 0.000 description 1
- 102220020391 rs397508224 Human genes 0.000 description 1
- 102200128209 rs397508225 Human genes 0.000 description 1
- 102200128205 rs397508241 Human genes 0.000 description 1
- 102220020405 rs397508247 Human genes 0.000 description 1
- 102220020410 rs397508255 Human genes 0.000 description 1
- 102220020413 rs397508260 Human genes 0.000 description 1
- 102200128222 rs397508267 Human genes 0.000 description 1
- 102220020420 rs397508270 Human genes 0.000 description 1
- 102220020421 rs397508272 Human genes 0.000 description 1
- 102220020424 rs397508275 Human genes 0.000 description 1
- 102200128223 rs397508276 Human genes 0.000 description 1
- 102200128224 rs397508276 Human genes 0.000 description 1
- 102200128226 rs397508277 Human genes 0.000 description 1
- 102200128233 rs397508280 Human genes 0.000 description 1
- 102200128231 rs397508282 Human genes 0.000 description 1
- 102220020427 rs397508283 Human genes 0.000 description 1
- 102220020429 rs397508285 Human genes 0.000 description 1
- 102220020430 rs397508286 Human genes 0.000 description 1
- 102220020431 rs397508287 Human genes 0.000 description 1
- 102200128244 rs397508288 Human genes 0.000 description 1
- 102220020432 rs397508288 Human genes 0.000 description 1
- 102220020435 rs397508291 Human genes 0.000 description 1
- 102220020436 rs397508293 Human genes 0.000 description 1
- 102220020437 rs397508293 Human genes 0.000 description 1
- 102220020440 rs397508297 Human genes 0.000 description 1
- 102220020443 rs397508300 Human genes 0.000 description 1
- 102220020445 rs397508300 Human genes 0.000 description 1
- 102220020449 rs397508305 Human genes 0.000 description 1
- 102220020452 rs397508308 Human genes 0.000 description 1
- 102220020453 rs397508308 Human genes 0.000 description 1
- 102220020455 rs397508309 Human genes 0.000 description 1
- 102220020456 rs397508310 Human genes 0.000 description 1
- 102220020457 rs397508310 Human genes 0.000 description 1
- 102200128239 rs397508311 Human genes 0.000 description 1
- 102200128265 rs397508313 Human genes 0.000 description 1
- 102200128262 rs397508314 Human genes 0.000 description 1
- 102200128263 rs397508315 Human genes 0.000 description 1
- 102220020458 rs397508317 Human genes 0.000 description 1
- 102200128268 rs397508318 Human genes 0.000 description 1
- 102220243424 rs397508330 Human genes 0.000 description 1
- 102220020469 rs397508332 Human genes 0.000 description 1
- 102220020471 rs397508335 Human genes 0.000 description 1
- 102220020485 rs397508352 Human genes 0.000 description 1
- 102220020491 rs397508359 Human genes 0.000 description 1
- 102200128279 rs397508363 Human genes 0.000 description 1
- 102220020495 rs397508369 Human genes 0.000 description 1
- 102200128277 rs397508373 Human genes 0.000 description 1
- 102220020501 rs397508375 Human genes 0.000 description 1
- 102200128276 rs397508378 Human genes 0.000 description 1
- 102200128248 rs397508381 Human genes 0.000 description 1
- 102220020509 rs397508392 Human genes 0.000 description 1
- 102220020512 rs397508395 Human genes 0.000 description 1
- 102220020513 rs397508397 Human genes 0.000 description 1
- 102220020517 rs397508402 Human genes 0.000 description 1
- 102200128618 rs397508403 Human genes 0.000 description 1
- 102220020523 rs397508412 Human genes 0.000 description 1
- 102220020526 rs397508417 Human genes 0.000 description 1
- 102220020527 rs397508418 Human genes 0.000 description 1
- 102220020529 rs397508421 Human genes 0.000 description 1
- 102220450597 rs397508422 Human genes 0.000 description 1
- 102200128249 rs397508428 Human genes 0.000 description 1
- 102220020535 rs397508429 Human genes 0.000 description 1
- 102220020536 rs397508430 Human genes 0.000 description 1
- 102220450595 rs397508432 Human genes 0.000 description 1
- 102220020543 rs397508435 Human genes 0.000 description 1
- 102220020544 rs397508436 Human genes 0.000 description 1
- 102220020545 rs397508437 Human genes 0.000 description 1
- 102220020546 rs397508439 Human genes 0.000 description 1
- 102220020548 rs397508442 Human genes 0.000 description 1
- 102220020549 rs397508444 Human genes 0.000 description 1
- 102220020550 rs397508444 Human genes 0.000 description 1
- 102200128258 rs397508448 Human genes 0.000 description 1
- 102220020556 rs397508449 Human genes 0.000 description 1
- 102220020558 rs397508453 Human genes 0.000 description 1
- 102220020559 rs397508453 Human genes 0.000 description 1
- 102220020561 rs397508459 Human genes 0.000 description 1
- 102220020562 rs397508460 Human genes 0.000 description 1
- 102220020565 rs397508462 Human genes 0.000 description 1
- 102220020566 rs397508462 Human genes 0.000 description 1
- 102220020567 rs397508463 Human genes 0.000 description 1
- 102200128586 rs397508464 Human genes 0.000 description 1
- 102220020552 rs397508464 Human genes 0.000 description 1
- 102220020568 rs397508467 Human genes 0.000 description 1
- 102220020569 rs397508468 Human genes 0.000 description 1
- 102220020570 rs397508469 Human genes 0.000 description 1
- 102200128254 rs397508479 Human genes 0.000 description 1
- 102200128260 rs397508480 Human genes 0.000 description 1
- 102220020579 rs397508483 Human genes 0.000 description 1
- 102220020586 rs397508488 Human genes 0.000 description 1
- 102220020587 rs397508490 Human genes 0.000 description 1
- 102220339060 rs397508490 Human genes 0.000 description 1
- 102220020588 rs397508491 Human genes 0.000 description 1
- 102220390305 rs397508494 Human genes 0.000 description 1
- 102220020596 rs397508504 Human genes 0.000 description 1
- 102220020599 rs397508510 Human genes 0.000 description 1
- 102220020600 rs397508511 Human genes 0.000 description 1
- 102220020602 rs397508513 Human genes 0.000 description 1
- 102220020611 rs397508520 Human genes 0.000 description 1
- 102220020612 rs397508521 Human genes 0.000 description 1
- 102220020614 rs397508522 Human genes 0.000 description 1
- 102220020616 rs397508523 Human genes 0.000 description 1
- 102220020609 rs397508527 Human genes 0.000 description 1
- 102200132011 rs397508531 Human genes 0.000 description 1
- 102220020626 rs397508535 Human genes 0.000 description 1
- 102220020630 rs397508539 Human genes 0.000 description 1
- 102220020632 rs397508541 Human genes 0.000 description 1
- 102220020633 rs397508542 Human genes 0.000 description 1
- 102220020637 rs397508546 Human genes 0.000 description 1
- 102220020639 rs397508550 Human genes 0.000 description 1
- 102200132010 rs397508553 Human genes 0.000 description 1
- 102200132070 rs397508555 Human genes 0.000 description 1
- 102220339143 rs397508555 Human genes 0.000 description 1
- 102200132068 rs397508556 Human genes 0.000 description 1
- 102220020641 rs397508558 Human genes 0.000 description 1
- 102220020643 rs397508562 Human genes 0.000 description 1
- 102220020645 rs397508565 Human genes 0.000 description 1
- 102200132007 rs397508567 Human genes 0.000 description 1
- 102220020646 rs397508568 Human genes 0.000 description 1
- 102200132069 rs397508569 Human genes 0.000 description 1
- 102220020648 rs397508571 Human genes 0.000 description 1
- 102220450633 rs397508572 Human genes 0.000 description 1
- 102220020649 rs397508573 Human genes 0.000 description 1
- 102220020650 rs397508574 Human genes 0.000 description 1
- 102220020652 rs397508577 Human genes 0.000 description 1
- 102220020662 rs397508592 Human genes 0.000 description 1
- 102220020663 rs397508593 Human genes 0.000 description 1
- 102220020664 rs397508594 Human genes 0.000 description 1
- 102220020670 rs397508598 Human genes 0.000 description 1
- 102220020671 rs397508600 Human genes 0.000 description 1
- 102220020672 rs397508602 Human genes 0.000 description 1
- 102220020674 rs397508603 Human genes 0.000 description 1
- 102220020678 rs397508607 Human genes 0.000 description 1
- 102220020679 rs397508609 Human genes 0.000 description 1
- 102200132113 rs397508616 Human genes 0.000 description 1
- 102220020690 rs397508619 Human genes 0.000 description 1
- 102200132110 rs397508621 Human genes 0.000 description 1
- 102220020698 rs397508634 Human genes 0.000 description 1
- 102200128607 rs397508635 Human genes 0.000 description 1
- 102220020699 rs397508636 Human genes 0.000 description 1
- 102220020702 rs397508640 Human genes 0.000 description 1
- 102220020704 rs397508641 Human genes 0.000 description 1
- 102220020708 rs397508646 Human genes 0.000 description 1
- 102220020711 rs397508648 Human genes 0.000 description 1
- 102220020713 rs397508653 Human genes 0.000 description 1
- 102220020719 rs397508658 Human genes 0.000 description 1
- 102220020720 rs397508659 Human genes 0.000 description 1
- 102220020721 rs397508660 Human genes 0.000 description 1
- 102220020726 rs397508666 Human genes 0.000 description 1
- 102200132117 rs397508670 Human genes 0.000 description 1
- 102220020730 rs397508674 Human genes 0.000 description 1
- 102220457918 rs397508678 Human genes 0.000 description 1
- 102220020736 rs397508682 Human genes 0.000 description 1
- 102220020741 rs397508688 Human genes 0.000 description 1
- 102200132123 rs397508691 Human genes 0.000 description 1
- 102220457926 rs397508692 Human genes 0.000 description 1
- 102220020744 rs397508696 Human genes 0.000 description 1
- 102220020746 rs397508697 Human genes 0.000 description 1
- 102220020747 rs397508699 Human genes 0.000 description 1
- 102200128594 rs397508700 Human genes 0.000 description 1
- 102220020750 rs397508703 Human genes 0.000 description 1
- 102220020755 rs397508708 Human genes 0.000 description 1
- 102200128592 rs397508718 Human genes 0.000 description 1
- 102220020765 rs397508720 Human genes 0.000 description 1
- 102220020767 rs397508721 Human genes 0.000 description 1
- 102220243752 rs397508721 Human genes 0.000 description 1
- 102220020768 rs397508722 Human genes 0.000 description 1
- 102220020769 rs397508723 Human genes 0.000 description 1
- 102220020770 rs397508725 Human genes 0.000 description 1
- 102220020771 rs397508727 Human genes 0.000 description 1
- 102220020772 rs397508729 Human genes 0.000 description 1
- 102220020773 rs397508729 Human genes 0.000 description 1
- 102220457794 rs397508731 Human genes 0.000 description 1
- 102220020778 rs397508736 Human genes 0.000 description 1
- 102220020788 rs397508744 Human genes 0.000 description 1
- 102220020791 rs397508747 Human genes 0.000 description 1
- 102220020793 rs397508748 Human genes 0.000 description 1
- 102220020798 rs397508751 Human genes 0.000 description 1
- 102220339005 rs397508753 Human genes 0.000 description 1
- 102220020800 rs397508754 Human genes 0.000 description 1
- 102220020801 rs397508755 Human genes 0.000 description 1
- 102220020802 rs397508756 Human genes 0.000 description 1
- 102220020803 rs397508758 Human genes 0.000 description 1
- 102200128598 rs397508759 Human genes 0.000 description 1
- 102220020807 rs397508762 Human genes 0.000 description 1
- 102220020809 rs397508764 Human genes 0.000 description 1
- 102200128189 rs397508765 Human genes 0.000 description 1
- 102220020810 rs397508766 Human genes 0.000 description 1
- 102220020814 rs397508770 Human genes 0.000 description 1
- 102220020815 rs397508772 Human genes 0.000 description 1
- 102220020819 rs397508776 Human genes 0.000 description 1
- 102200128184 rs397508780 Human genes 0.000 description 1
- 102220020823 rs397508782 Human genes 0.000 description 1
- 102200128185 rs397508783 Human genes 0.000 description 1
- 102220020824 rs397508784 Human genes 0.000 description 1
- 102220020826 rs397508788 Human genes 0.000 description 1
- 102220020827 rs397508789 Human genes 0.000 description 1
- 102220020830 rs397508792 Human genes 0.000 description 1
- 102220020835 rs397508797 Human genes 0.000 description 1
- 102220020838 rs397508800 Human genes 0.000 description 1
- 102220020840 rs397508802 Human genes 0.000 description 1
- 102200128190 rs397508804 Human genes 0.000 description 1
- 102220020843 rs397508811 Human genes 0.000 description 1
- 102220020844 rs397508812 Human genes 0.000 description 1
- 102220020846 rs397508814 Human genes 0.000 description 1
- 102200128197 rs397508817 Human genes 0.000 description 1
- 102220020849 rs397508818 Human genes 0.000 description 1
- 102220339026 rs397508818 Human genes 0.000 description 1
- 102220339099 rs397508818 Human genes 0.000 description 1
- 102200128194 rs397508819 Human genes 0.000 description 1
- 102220020850 rs397508822 Human genes 0.000 description 1
- 102220457736 rs397508825 Human genes 0.000 description 1
- 102200132124 rs4148725 Human genes 0.000 description 1
- 102220020577 rs55803548 Human genes 0.000 description 1
- 102220457737 rs56093012 Human genes 0.000 description 1
- 102220261862 rs578029902 Human genes 0.000 description 1
- 102220039896 rs587778073 Human genes 0.000 description 1
- 102220018504 rs73215912 Human genes 0.000 description 1
- 102200132015 rs74503330 Human genes 0.000 description 1
- 102200128182 rs74551128 Human genes 0.000 description 1
- 102200128210 rs74571530 Human genes 0.000 description 1
- 102220291483 rs745756794 Human genes 0.000 description 1
- 102220020408 rs74597325 Human genes 0.000 description 1
- 102220262482 rs749784731 Human genes 0.000 description 1
- 102220007489 rs75053309 Human genes 0.000 description 1
- 102220338824 rs752617117 Human genes 0.000 description 1
- 102200132019 rs75389940 Human genes 0.000 description 1
- 102200128219 rs75527207 Human genes 0.000 description 1
- 102200132008 rs75541969 Human genes 0.000 description 1
- 102200128215 rs75549581 Human genes 0.000 description 1
- 102200128196 rs75763344 Human genes 0.000 description 1
- 102200128218 rs75789129 Human genes 0.000 description 1
- 102200128617 rs75961395 Human genes 0.000 description 1
- 102220020511 rs75961395 Human genes 0.000 description 1
- 102220339145 rs762224063 Human genes 0.000 description 1
- 102220261896 rs762847468 Human genes 0.000 description 1
- 102200128597 rs76371115 Human genes 0.000 description 1
- 102220020742 rs76371115 Human genes 0.000 description 1
- 102220293799 rs764434414 Human genes 0.000 description 1
- 102220020676 rs76649725 Human genes 0.000 description 1
- 102220319782 rs766541549 Human genes 0.000 description 1
- 102220020361 rs76727851 Human genes 0.000 description 1
- 102220339128 rs768589673 Human genes 0.000 description 1
- 102200128172 rs76879328 Human genes 0.000 description 1
- 102220339204 rs769931559 Human genes 0.000 description 1
- 102220020447 rs77284892 Human genes 0.000 description 1
- 102220295126 rs773018372 Human genes 0.000 description 1
- 102200128193 rs77409459 Human genes 0.000 description 1
- 102200128207 rs77646904 Human genes 0.000 description 1
- 102220008549 rs77646904 Human genes 0.000 description 1
- 102220078865 rs776745618 Human genes 0.000 description 1
- 102220261648 rs777850419 Human genes 0.000 description 1
- 102220339137 rs778175128 Human genes 0.000 description 1
- 102200128590 rs77834169 Human genes 0.000 description 1
- 102220020653 rs77834169 Human genes 0.000 description 1
- 102200132111 rs77902683 Human genes 0.000 description 1
- 102220020687 rs77902683 Human genes 0.000 description 1
- 102200128168 rs77932196 Human genes 0.000 description 1
- 102200128169 rs77932196 Human genes 0.000 description 1
- 102200128171 rs77932196 Human genes 0.000 description 1
- 102220020613 rs77958296 Human genes 0.000 description 1
- 102200132028 rs78194216 Human genes 0.000 description 1
- 102220020604 rs78194216 Human genes 0.000 description 1
- 102200128588 rs78655421 Human genes 0.000 description 1
- 102200128589 rs78655421 Human genes 0.000 description 1
- 102200128591 rs78655421 Human genes 0.000 description 1
- 102220119074 rs78742051 Human genes 0.000 description 1
- 102200132033 rs78769542 Human genes 0.000 description 1
- 102200132036 rs78769542 Human genes 0.000 description 1
- 102200128179 rs79282516 Human genes 0.000 description 1
- 102220020377 rs79282516 Human genes 0.000 description 1
- 102200132030 rs79635528 Human genes 0.000 description 1
- 102200132108 rs80034486 Human genes 0.000 description 1
- 102200128221 rs80055610 Human genes 0.000 description 1
- 102200128229 rs80055610 Human genes 0.000 description 1
- 102200128599 rs80282562 Human genes 0.000 description 1
- 102220258069 rs935976612 Human genes 0.000 description 1
- 102220290969 rs962313398 Human genes 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 201000000306 sarcoidosis Diseases 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 238000002805 secondary assay Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 201000009881 secretory diarrhea Diseases 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229960003310 sildenafil Drugs 0.000 description 1
- 238000002603 single-photon emission computed tomography Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000003594 spinal ganglia Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 210000003568 synaptosome Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000001779 taste bud Anatomy 0.000 description 1
- 210000000108 taste bud cell Anatomy 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000028973 vesicle-mediated transport Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
- C12Y306/03—Hydrolases acting on acid anhydrides (3.6) acting on acid anhydrides; catalysing transmembrane movement of substances (3.6.3)
- C12Y306/03049—Channel-conductance-controlling ATPase (3.6.3.49)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
- G01N2800/382—Cystic fibrosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14931209P | 2009-02-02 | 2009-02-02 | |
| PCT/US2010/022778 WO2010088630A2 (en) | 2009-02-02 | 2010-02-01 | Cell lines expressing cftr and methods of using them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2011008131A true MX2011008131A (es) | 2012-01-20 |
Family
ID=42396394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011008131A MX2011008131A (es) | 2009-02-02 | 2010-02-01 | Lineas celulares que expresan cftr y los métodos para utilizarlas. |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20120058918A1 (enExample) |
| EP (1) | EP2393930A4 (enExample) |
| JP (1) | JP2012516686A (enExample) |
| CA (1) | CA2751215A1 (enExample) |
| MX (1) | MX2011008131A (enExample) |
| WO (1) | WO2010088630A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2245046B1 (en) * | 2008-01-22 | 2019-09-04 | Chromocell Corporation | Novel cell lines expressing nav and methods using them |
| CA2713885A1 (en) * | 2008-02-01 | 2009-08-20 | Chromocell Corporation | Novel cell lines and methods |
| WO2011014740A2 (en) | 2009-07-31 | 2011-02-03 | Chromocell Corporation | Methods and composition for identifying and validating modulators of cell fate |
| WO2012162468A1 (en) * | 2011-05-25 | 2012-11-29 | Janssen Pharmaceutica Nv | Thiazol derivatives as pro -matrix metalloproteinase inhibitors |
| US20130014288A1 (en) * | 2011-06-06 | 2013-01-10 | Carnegie Mellon University | Novel reporter-tagged recombinant membrane proteins with transmembrane linkers |
| FR2999191B1 (fr) * | 2012-12-12 | 2016-02-05 | Lesaffre & Cie | Souches probiotiques pour le traitement et/ou la prevention de la diarrhee |
| WO2017196843A1 (en) * | 2016-05-09 | 2017-11-16 | Proteostasis Therapeutics, Inc. | Methods of identifying cftr modulators |
| US11723579B2 (en) | 2017-09-19 | 2023-08-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement |
| US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
| US12280219B2 (en) | 2017-12-31 | 2025-04-22 | NeuroLight, Inc. | Method and apparatus for neuroenhancement to enhance emotional response |
| US11478603B2 (en) | 2017-12-31 | 2022-10-25 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
| US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
| WO2020056418A1 (en) | 2018-09-14 | 2020-03-19 | Neuroenhancement Lab, LLC | System and method of improving sleep |
| US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
| CN111910008B (zh) * | 2020-08-21 | 2022-05-31 | 云南农业大学 | 一种鸡生长发育相关的分子标记及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020164782A1 (en) * | 1999-02-10 | 2002-11-07 | Gregory Richard J. | Adenovirus vectors for gene therapy |
| WO2001003722A1 (en) * | 1999-07-09 | 2001-01-18 | Mayo Foundation For Medical Education And Research | Cftr polypeptides, fragments thereof and methods of use to overcome biosynthetic misprocessing |
| WO2004020596A2 (en) * | 2002-08-30 | 2004-03-11 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Polypeptides for increasing mutant cftr channel activity |
| AU2005251745A1 (en) * | 2004-06-04 | 2005-12-22 | The Regents Of The University Of California | Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof |
| WO2006101740A2 (en) * | 2005-03-18 | 2006-09-28 | The Regents Of The University Of California | Compounds having activity in correcting mutant-cftr processing and uses thereof |
| CA2602793C (en) * | 2005-04-13 | 2016-11-22 | Astrazeneca Ab | A host cell comprising a vector for production of proteins requiring gamma-carboxylation |
| MX2008014437A (es) * | 2006-05-19 | 2008-11-27 | Scripps Research Inst | Tratamiento de desplegamiento de proteinas. |
| WO2008121199A2 (en) * | 2007-03-28 | 2008-10-09 | University Of Iowa Research Foundation | Transgenic animal models of disease |
-
2010
- 2010-02-01 US US13/147,327 patent/US20120058918A1/en not_active Abandoned
- 2010-02-01 MX MX2011008131A patent/MX2011008131A/es not_active Application Discontinuation
- 2010-02-01 JP JP2011548377A patent/JP2012516686A/ja active Pending
- 2010-02-01 CA CA2751215A patent/CA2751215A1/en not_active Abandoned
- 2010-02-01 EP EP10736545A patent/EP2393930A4/en not_active Withdrawn
- 2010-02-01 WO PCT/US2010/022778 patent/WO2010088630A2/en not_active Ceased
-
2014
- 2014-11-24 US US14/552,192 patent/US20150315554A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2393930A4 (en) | 2012-08-15 |
| CA2751215A1 (en) | 2010-08-05 |
| EP2393930A2 (en) | 2011-12-14 |
| US20120058918A1 (en) | 2012-03-08 |
| WO2010088630A3 (en) | 2010-11-25 |
| US20150315554A1 (en) | 2015-11-05 |
| JP2012516686A (ja) | 2012-07-26 |
| WO2010088630A2 (en) | 2010-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011008131A (es) | Lineas celulares que expresan cftr y los métodos para utilizarlas. | |
| Boeckers et al. | C‐terminal synaptic targeting elements for postsynaptic density proteins ProSAP1/Shank2 and ProSAP2/Shank3 | |
| Quamme | Molecular identification of ancient and modern mammalian magnesium transporters | |
| Carneiro et al. | The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter | |
| Ma et al. | Diverse trafficking patterns due to multiple traffic motifs in G protein-activated inwardly rectifying potassium channels from brain and heart | |
| ES2640817T3 (es) | Líneas celulares que expresan Nav y métodos para su utilización | |
| Piters et al. | First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function | |
| CN103525751B (zh) | 细胞系以及制备和使用其的方法 | |
| US20100105625A1 (en) | Product and Methods for Diagnosis and Therapy for Cardiac and Skeletal Muscle Disorders | |
| Tan et al. | Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation | |
| Park et al. | Fine-tuning GPCR-mediated neuromodulation by biasing signaling through different G protein subunits | |
| Stefanski et al. | How T118M peripheral myelin protein 22 predisposes humans to Charcot–Marie–Tooth disease | |
| Boileau et al. | The short splice variant of the γ2 subunit acts as an external modulator of GABAA receptor function | |
| Du et al. | Functional characterization of novel NPRL3 mutations identified in three families with focal epilepsy | |
| Edelheit et al. | Identification of the roles of conserved charged residues in the extracellular domain of an epithelial sodium channel (ENaC) subunit by alanine mutagenesis | |
| KR20070092767A (ko) | 시노비올린 활성 조절 작용의 검출 방법 | |
| Larasati et al. | Novel Mutation at Cys225 in GNAO1‐Associated Developmental and Epileptic Encephalopathies: Clinical, Molecular, and Pharmacological Profiling of Case Studies | |
| EP3940384A1 (en) | Method for screening compound for treating or preventing polyq-related neurodegenerative diseases | |
| Dubreuil | Molecular and genetic dissection of the membrane skeleton in Drosophila | |
| Gu et al. | The middle lipin (M-Lip) domain is a new dimeric protein fold that binds membranes | |
| Dahimene et al. | The interplay between splicing of exons 18a and 47 differentially affects membrane targeting and function of human CaV2. 2 | |
| Deb et al. | DE NOVO VARIANTS IN THE POLY (RC)-BINDING PROTEIN GENE PCBP1 CAUSE A NEURODEVELOPMENTAL DISORDER | |
| WO2002103057A1 (en) | Methods for identifying modulators of nf-kb activity | |
| Yan et al. | Long-read sequencing-based atlas of tissue-specific expression of Drp1 transcript variants | |
| Zhang et al. | Novel Compound Heterozygous Pathogenic Mutations of SLC5A5 Novel Compound Heterozygous Pathogenic Mutations of SLC5A5 in a Chinese Patient With Congenital Hypothyroidism Cao-Xu Zhang¹†, Jun-Xiu Zhang2†, Liu Yang¹, Chang-Run Zhang¹ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |